Skip to content
★ Sign in to follow
CF

Christer Fåhraeus

EQL PharmaEQL Pharma AB
Insider activity · 24 months1 buy1 saleCumulative net flow
Total declarations
24
Companies
2
▲ Purchases (14 ops.)
€1.1M
▼ Sales (9 ops.)
€6.3M

Latest filing published 05 Sept 2025 for EQL Pharma AB.

Filing timeline

BuySale
Christer Fåhraeus

Insider track record

Disclosed buys
14
Disclosed sells
9
Signal history

Closed purchases

Market purchases
14

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Christer Fåhraeus: trading record in brief

Christer Fåhraeus has filed trades across 2 companies (mainly through Finansinspektionen), most often in EQL Pharma AB and EQL Pharma. We count 24 filings; the first trade dates from 5 November 2018 and the latest from 3 September 2025.

Market trades split into 14 purchases (€1.1M) and 9 sales (€6.3M). The net balance comes to €5.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 1 purchase and 1 sale.

In size, the median ticket on the buying side is €17k. Clusters matter here: 2 out of 12 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 5 September 2025, the filings show a transaction in EQL Pharma AB. The latest purchase dates back some time: it was published 446 days ago, on 18 August 2025. The median gap between a trade and its publication by Finansinspektionen is 2 days. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Christer Fåhraeus

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total
  • ●
    StyrelseordförandeExecutivesEQL Pharma AB
    0FI-SE
    345,642 shares0AktieISIN SE0005497732FI:csv-dbdde11ca5fa07bae900
  • ▲
    StyrelseordförandeExecutivesEQL Pharma AB
    265,464 SEK7FI-SE
    3,129 shares@ SEK 84.840.5% of flowAktieISIN SE0005497732FI:csv-f0f8761ae70c1ed050db
    Canonical exit: 12 Nov 2025 (T+90)
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    9M SEK9FI-SE
    100,000 shares@ SEK 86.2016.2% of flowAktieISIN SE0005497732FI:csv-c40b6a0f54c5b7663618
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    600,000 SEK7FI-SE
    10,000 shares@ SEK 60.001.0% of flowAktieISIN SE0005497732FI:csv-86590df1df8788c802ee
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    2M SEK7FI-SE
    26,000 shares@ SEK 63.77992.9% of flowAktieISIN SE0005497732FI:csv-56aa9a30d0e32dd2a347
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    10M SEK9FI-SE
    300,000 shares@ SEK 33.0017.6% of flowAktieISIN SE0005497732FI:csv-20bf886f9027df635b01
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    3M SEK7FI-SE
    90,000 shares@ SEK 30.224.8% of flowAktieISIN SE0005497732FI:csv-cc94c3ce139bdf092f04
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    31M SEK24FI-SE
    1,000,000 shares@ SEK 30.5053.1% of flowAktieISIN SE0005497732FI:csv-1847872df619a2cac5a2
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    11M SEK9FI-SE
    300,000 shares@ SEK 37.5023.1% of flowAktieISIN SE0005497732FI:csv-47abf3c80ed1cab35f6e
  • ▼
    StyrelseordförandeExecutivesEQL Pharma AB
    3M SEK8FI-SE
    208,000 shares@ SEK 16.007.1% of flowAktieISIN SE0005497732FI:csv-94605a8fe2a4e914d97c
  • ▲
    StyrelseordförandeExecutivesEQL Pharma AB
    426,000 SEK7FI-SE
    15,000 shares@ SEK 28.400.9% of flowAktieISIN SE0005497732FI:csv-4535c12f7c96e2cdcb30
    Canonical exit: 12 Feb 2023 (T+90)
  • ▲
    StyrelseordförandeExecutivesEQL Pharma AB
    142,000 SEK7FI-SE
    5,000 shares@ SEK 28.400.3% of flowAktieISIN SE0005497732FI:csv-f4fcae3a8a69111bf7b7
    Canonical exit: 26 Dec 2022 (T+90)
  • ▲
    StyrelseordförandeExecutivesEQL Pharma AB
    143,000 SEK7FI-SE
    5,000 shares@ SEK 28.600.3% of flowAktieISIN SE0005497732FI:csv-2a91cf48d110b150fe18
    Canonical exit: 27 Dec 2022 (T+90)
  • ▲
    StyrelseordförandeExecutivesEQL Pharma AB
    141,500 SEK7FI-SE
    5,000 shares@ SEK 28.300.3% of flowAktieISIN SE0005497732FI:csv-c9e1e3b980cd8be4f786
    Canonical exit: 28 Dec 2022 (T+90)
  • ▲
    StyrelseordförandeExecutivesEQL Pharma AB
    1M SEK7FI-SE
    45,077 shares@ SEK 29.992.9% of flowAktieISIN SE0005497732FI:csv-68ecbbdabfd059c17647
    Canonical exit: 15 Dec 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesEQL Pharma AB
    134,750 SEK22FI-SE
    5,000 shares@ SEK 26.950.4% of flowAktieISIN SE0005497732FI:csv-66b0c71ec1d7f8c0d231
    Canonical exit: 15 Sept 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesEQL Pharma AB
    38,826 SEK22FI-SE
    1,438 shares@ SEK 27.000.1% of flowAktieISIN SE0005497732FI:csv-63abb7332c111214acb2
    Canonical exit: 15 Sept 2022 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesEQL Pharma AB
    50,004 SEK22FI-SE
    1,852 shares@ SEK 27.000.2% of flowAktieISIN SE0005497732FI:csv-e75c2dc0b8ac444ed18c
    Canonical exit: 18 Sept 2022 (T+90)
  • ▼
    Verkställande direktör (VD)ExecutivesEQL Pharma AB
    3M SEK35FI-SE
    200,000 shares@ SEK 15.006.8% of flowAktieISIN SE0005497732FI:csv-a89565e3dcfc0db660f6
  • ▲
    Verkställande direktör (VD)ExecutivesEQL Pharma AB
    224,664 SEK34FI-SE
    6,105 shares@ SEK 36.800.5% of flowAktieISIN SE0005497732FI:csv-7b866eff5b463e7a171c
    Canonical exit: 21 Nov 2021 (T+90)
  • ▲
    VDExecutivesEQL Pharma AB
    7M SEK25FI-SE
    582,776 shares@ SEK 12.0026.5% of flowAktieISIN SE0005497732FI:csv-57f2c50abecd5ad5e179
    Canonical exit: 29 Jul 2019 (T+90)
  • ▲
    VDExecutivesEQL Pharma
    168,300 SEK35FI-SE
    17,000 shares@ SEK 9.9010.1% of flowAktieISIN SE0005497732FI:csv-39625fef6d9e9ec79e27
    Canonical exit: 6 Feb 2019 (T+90)
  • ▲
    VDExecutivesEQL Pharma
    1M SEK0FI-SE
    3,231,865 shares@ SEK 0.4078.4% of flowTeckningsrättISIN SE0011844166FI:csv-d49de7e8ece44c241cff
    Canonical exit: 7 Feb 2019 (T+90)
  • ▲
    VDExecutivesEQL Pharma
    190,080 SEK0FI-SE
    316,800 shares@ SEK 0.6011.5% of flowTeckningsrättISIN SE0011844166FI:csv-e5afd4c3a0d037f24ada
    Canonical exit: 3 Feb 2019 (T+90)

24 of 24 declarations